🔎 Trials Near Me

Home › Scleroderma › Connecticut › New Haven

Scleroderma clinical trials in New Haven, CT

4 studies for Scleroderma are looking for participants at sites in and around New Haven (within about 30 miles). Open a study to see who can join and how to contact the study team.

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

RecruitingPhase 1
  • Smilow Cancer Center/Yale-New Haven Hospital, New Haven
  • Yale University, New Haven
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

RecruitingPhase 2/3
  • Yale University, New Haven
Ages 18 to 75 · All sexes · Updated Aug 17, 2026 · NCT06328777

Quantification of Calcinosis Cutis Disease Burden Using Computed Tomography Images

RecruitingObservational study
  • Yale Scleroderma Program, New Haven
Ages 18 and older · All sexes · Updated Feb 17, 2026 · NCT07228429

Rheumatology Patient Registry and Biorepository

RecruitingObservational studyHealthy volunteers welcome
  • Yale New Haven Hospital, New Haven
Ages 18 to 99 · All sexes · Updated Feb 13, 2026 · NCT04402086

About Scleroderma

Scleroderma is an autoimmune disease that causes inflammation and thickening in the skin and other areas of the body. The exact cause of scleroderma is unknown.

More about Scleroderma on MedlinePlus

Scleroderma trials in other cities

Other studies in New Haven

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.